|
CV Fibrosis & BRD4 i’s
|
3
|
Resverlogix Corp.
|
Aug 15, 2019 09:53AM
|
|
Re: AHA 2018
|
3
|
Resverlogix Corp.
|
Nov 11, 2018 05:03AM
|
|
J&J Abiraterone going generic
|
4
|
Zenith Epigenetics
|
Nov 21, 2018 02:31PM
|
|
Re: Insider Selling
|
4
|
Resverlogix Corp.
|
Jul 13, 2019 09:06PM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 11, 2018 11:46PM
|
|
Re: Classifying/taxonomy mCRPC patients
|
4
|
Zenith Epigenetics
|
Apr 20, 2019 03:44PM
|
|
Re: Insider Selling
|
4
|
Resverlogix Corp.
|
Jul 11, 2019 09:17PM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 12, 2018 09:22AM
|
|
Re: Roth research report
|
4
|
Resverlogix Corp.
|
Nov 01, 2018 09:14AM
|
|
Re: Shawn lu RSU and option cancelled
|
4
|
Resverlogix Corp.
|
Apr 07, 2020 10:25AM
|
|
Lending Shares
|
4
|
Resverlogix Corp.
|
Jul 29, 2019 11:54AM
|
|
Re: Shawn lu RSU and option cancelled
|
4
|
Resverlogix Corp.
|
Apr 07, 2020 12:27PM
|
|
Prostate Ca / Brd4
|
4
|
Zenith Epigenetics
|
Feb 21, 2019 09:49AM
|
|
Arvinas /ARVN dBET vs iBET
|
4
|
Zenith Epigenetics
|
Oct 12, 2018 08:03PM
|
|
Re: Amarin CEO interview
|
4
|
Resverlogix Corp.
|
Nov 12, 2018 02:35PM
|
|
Re: Last hour.....
|
4
|
Resverlogix Corp.
|
Jun 01, 2019 01:51AM
|
|
CKD Reata / Market Cap
|
4
|
Resverlogix Corp.
|
May 03, 2019 09:36AM
|
|
Re: Reata Nasdaq Symbol RETA
|
4
|
Resverlogix Corp.
|
May 03, 2019 10:07AM
|
|
Re: 3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 10:50AM
|
|
Endocyte Valuation
|
4
|
Zenith Epigenetics
|
Oct 18, 2018 02:14PM
|
